Jackson & Tucker, P.C.

1-866-252-3535
  • Home
  • Our Attorneys
    • K. Stephen Jackson
    • Joseph L. “Josh” Tucker
    • Representative Cases
  • Practice Areas
    • Personal Injury
    • Pharmaceutical Drug Injury
      • Beovu Dangers
      • Elmiron Dangers
      • Belviq & Cancer
      • Valsartan & Cancer
      • Zantac & Cancer
    • Product Defects
      • Baby Formula Dangers
      • Toxic Baby Foods
      • Paraquat Dangers
      • 3M Military Earplugs
      • Paragard Dangers
      • Talcum Powder & Cancer
      • “Mars Red” Paint Settlement
    • Nursing Home & Elder Abuse
    • Medical Malpractice
    • Catastrophic Injuries
      • Traumatic Brain Injuries
      • Spinal Cord Injuries
      • Burn Injuries
    • Mass Torts & Class Actions
    • Wrongful Death
    • Motor Vehicle Accidents
      • Auto Accidents
      • Motorcycle Accidents
      • Truck Accidents
    • Consumer Fraud & Deceptive Advertising
    • Pedestrian Accidents
    • Business Litigation
  • Currently Investigating
  • Contact Us
  • FAQ

SGLT2 Inhibitors

Jackson & Tucker, P.C. - Personal Injury LawyersUPDATE: (May 2019) – A new study published May 6th in the journal Annals of Internal Medicine, indicates the risk of developing “Fournier’s gangrene” from taking SGLT-2 Inhibitors is greater than initially believed. The researchers, examining information from the FDA’s Adverse Reporting System, discovered “Fournier’s gangrene” occurred in 55 people taking SGLT-2 Inhibitors (Invokana, Invokamet, Farxiga & Jardiance) between March 1, 2013, and January 31, 2019. In comparison, researchers found only 19 cases of the disease in people taking other diabetes medications between 1984 and January 31, 2019.

“Fournier’s gangrene” is an necrotizing infection that affects the tissue, muscles, fat, nerves and blood vessels of the perineum; the area around/between the genitals and the rectum. The condition can cause extreme pain in the scrotum, penis, vulva, vagina, or anal areas, as well as fever and a general, overall feeling of fatigue and illness. The affected area may appear red, emit a foul odor, and become gangrenous causing tissue to die. If left untreated, “Fournier’s gangrene” can spread to the thighs, into the abdominal wall, and up to the chest. The condition is generally treated with broad-spectrum antibiotics to kill the infection, and surgery to remove dead tissue. The condition can quickly worsen and result in death.

If you or a loved one were diagnosed with “Fournier’s gangrene” after taking Invokana, Invokamet, Jardiance or Farxiga, contact us online or call us at 1-866-252-3535.

Do not stop taking any medication without consulting your healthcare provider.

Share this page...

How Can We Help You?

  • Privacy Policy
  • This field is for validation purposes and should be left unchanged.

Jackson & Tucker, P.C.
Black Diamond Building
2229 First Avenue North
Birmingham, AL 35203
Phone: 205-252-3535
Toll Free: 1-866-252-3535
Fax: 205-252-3536
  • Sign-up for Our Newsletter

    Get our firm and legal news sent directly to your email account!

  • This field is for validation purposes and should be left unchanged.

  • Home
  • Our Attorneys
  • Practice Areas
  • Currently Investigating
  • Contact Us
  • FAQ

Copyright © 2025 Jackson & Tucker, P.C. & Altrumedia, LLC · All Rights Reserved · Terms of Use · Accessibility Statement · Disclaimer